Depomed Inc said U.S. health regulators have approved the 1000 mg strength tablets of Glumetza, an extended-release formulation of metformin, for patients with type 2 diabetes. Reuters Health Information
Becton, Dickinson and Co said on Wednesday it received clearance from the U.S. Food and Drug Administration for a test to quickly identify the presence of two health care-associated infections: Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA). Reuters Health Information
Three case studies, in national health policy from three countries: USA (prescription drug safety), Australia (childhood immunization) and UK (hospital waiting times) are presented. Journal of Public Health
This article provides a framework for improving quality for national healthcare reform using the translation of available evidence of policy and managerial decisions. International Journal for Quality in Health Care
Home healthcare company Apria Healthcare Group Inc. restated past financial results after finding accounting errors, lowering its third-quarter earnings, according to a regulatory filing seen on Friday. Reuters Health Information
NANN 2007: Neonatal nurses practice in a highly specialized and high-risk setting where the margin for error is low and the potential for injury is high. Medscape Nurses
NANN 2007: Hospitals often trust that excellent clinical skills, budgeting wizardry, and good relationships with physicians will turn superior nurses into good leaders. It may not work that way. Medscape Nurses
NANN 2007: Did you know that procedures like total parenteral nutrition infusion, exchange transfusions, and extracorporeal membrane oxygenation (ECMO) put infants at special risk? Medscape Nurses
The chief executive of Schering-Plough Corp on Thursday said poor quality of ultrasound images hobbled a closely watched trial of its Vytorin cholesterol fighter, and stressed that the controversial study involved a "narrow population" of patients. Reuters Health Information
Europe has approved raltegravir tablets (Isentress); the Philippines has approved a tumor-targeted gene delivery product (Rexin-G); and Europe has approved panitumumab intravenous infusion (Vectibix). Medscape Medical News
